Login / Signup

Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease.

Ziqi LiuShihao HeZongsheng XuRan DuanLi YuanChu XiaoZhe YiRong Wang
Published in: BMC neurology (2020)
Clinical Trial Registration, Unique identifier: ChiCTR1900023610 . Registered 4 June 2019 - Prospective study registered.
Keyphrases
  • white matter
  • clinical trial
  • multiple sclerosis
  • middle cerebral artery
  • phase ii
  • ischemia reperfusion injury
  • open label
  • double blind
  • study protocol
  • cerebral ischemia